GLP-1
-
health6 Common Medications That May Lower Your Dementia Risk
Studies suggest flu shots, shingles vaccines, and other common drugs may reduce dementia risk. Here's what the latest research shows.
-
healthOzempic Breath: The Unsettling Keto-Like Side Effect Patients Are Reporting
Patients taking GLP-1 drugs report 'fishy' bad breath known as Ozempic breath. Experts discuss dehydration as the likely cause.
-
healthPeptide Boom Under Scrutiny: Doctors Issue Warnings on the 'Wild West' Market
Inside the rapidly growing peptide market. Doctors explain the risks and the crucial dos and don'ts as FDA weighs easing restrictions.
-
healthFDA Targets Copycat Weight-Loss Drugs, Limits Bulk Production
The FDA proposes removing Novo Nordisk and Eli Lilly's weight-loss drugs from a compounding list to curb unauthorized bulk production.
-
healthUS Prescription Drug Spending on Track to Exceed $1 Trillion, Fueled by GLP-1s
U.S. drug spending hit $915B in 2025, set to top $1T in 2026, driven by GLP-1 weight-loss drug demand. Eli Lilly and Novo Nordisk dominate the market.
-
healthIndia's Generic Drugmakers Disrupt Weight Loss Market with Cheaper Semaglutide
Indian pharma companies launch generic semaglutide, slashing costs up to 70% and aiming to supply the global market.
-
healthDoctor Flags 5 Common Pitfalls With Weight-Loss Drugs
A physician outlines critical mistakes patients make when using GLP-1 medications, emphasizing lifestyle changes, medical oversight, and proper nutrition for optimal results.
-
healthMedicare Delays GLP-1 Weight-Loss Drug Program Amid Insurer Concerns
Medicare will offer GLP-1 weight-loss drugs via a temporary bridge program, delaying a new initiative due to insurer hesitations. Permanent integration remains uncertain.